Market Closed

CRSP
CRISPR Therapeutics AG
$ 42.24
-0.89%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

CRISPR Therapeutics AG News

Latest CRISPR Therapeutics AG Stock News & CRSP Headlines

Crispr Therapeutics: The Recent 40% Drop In Short Interest Indicates Deteriorating Bearish Sentiment
4 days ago | seekingalpha.com
CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026
6 days ago | globenewswire.com
CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
7 days ago | globenewswire.com
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
9 days ago | zacks.com
CRSP's Q3 Loss Wider Than Expected, Sales Beat Estimates
11 days ago | zacks.com
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Tops Revenue Estimates
12 days ago | zacks.com
Casgevy Starts Paying Off for CRISPR: Rapid Earnings Reaction
12 days ago | fool.com
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
12 days ago | globenewswire.com
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
13 days ago | zacks.com
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
13 days ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CRSP
CRISPR Therapeutics AG
$ 42.24
-0.89%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago